Back
Actinium Pharmaceuticals, Inc. 10K Form
Sell
40
ATNM
Actinium Pharmaceuticals, Inc.
Last Price:
$1.44
Seasonality Move:
102.85%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ATNM News And Ratings
See the #1 stock for the next 7 days that we like better than ATNM
ATNM Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-6.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.44 |
| Price / Book: | 3.28 |
Profitability
| EPS (TTM): | -1.10910 |
|---|---|
| Net Income (TTM): | $-34.6M |
| Gross Margin: | $-811K |
| Return on Equity: | -133.63% |
| Return on Assets: | -49.88% |
Actinium Pharmaceuticals, Inc. Earnings Forecast
Key Actinium Pharmaceuticals, Inc. Financial Ratios
-
Per Share Earnings over the last 19 years have been positive in 13 years.
Actinium Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ATNM |
| CUSIP: | 00507W |
| Website: | actiniumpharma.com |
Debt
| Debt-to-Equity Ratio: | 0.08 |
|---|---|
| Current Ratio: | 7.96 |
| Quick Ratio: | 7.81 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ATNM Technical Analysis vs Fundamental Analysis
Sell
40
Actinium Pharmaceuticals, Inc. (ATNM)
is a Sell
Is Actinium Pharmaceuticals, Inc. a Buy or a Sell?
-
Actinium Pharmaceuticals, Inc. stock is rated a SellThe current Actinium Pharmaceuticals, Inc. [ATNM] share price is $1.45. The Score for ATNM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.